Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 28, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 061904

« Back to Dashboard
NDA 061904 describes ERYTHROMYCIN ETHYLSUCCINATE, which is a drug marketed by Alpharma Us Pharms, Arbor Pharms Llc, Parke Davis, Mylan, Ani Pharms Inc, Barr, Pharmafair, Naska, and Dista, and is included in eleven NDAs. It is available from four suppliers. Additional details are available on the ERYTHROMYCIN ETHYLSUCCINATE profile page.

The generic ingredient in ERYTHROMYCIN ETHYLSUCCINATE is erythromycin ethylsuccinate; sulfisoxazole acetyl. There are ninety-eight drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate; sulfisoxazole acetyl profile page.

Summary for NDA: 061904

Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 061904

Physiological EffectDecreased Sebaceous Gland Activity

Suppliers and Packaging for NDA: 061904

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
erythromycin ethylsuccinate
TABLET;ORAL 061904 ANDA Arbor Pharmaceuticals, Inc. 24338-110 24338-110-13 100 TABLET in 1 BOTTLE (24338-110-13)
erythromycin ethylsuccinate
TABLET;ORAL 061904 ANDA A-S Medication Solutions LLC 54569-2507 54569-2507-2 40 TABLET in 1 BOTTLE (54569-2507-2)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 400MG BASE
Approval Date:Approved Prior to Jan 1, 1982TE:BXRLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus